Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy

2015-12-01

British Journal of Cancer , Volume 113 - Issue 11 p. 1636

Additional Metadata
Persistent URL	doi.org/10.1038/bjc.2015.331, hdl.handle.net/1765/89138
Journal	British Journal of Cancer
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Cardillo, G, Mokhles, S, Williams, N, Macbeth, F, Russell, C, & Treasure, T. (2015). Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy. British Journal of Cancer, 113(11). doi:10.1038/bjc.2015.331

Additional Files
pubmedcentral Author Manuscript

Publication